ATE698T1 - Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE698T1
ATE698T1 AT79300756T AT79300756T ATE698T1 AT E698 T1 ATE698 T1 AT E698T1 AT 79300756 T AT79300756 T AT 79300756T AT 79300756 T AT79300756 T AT 79300756T AT E698 T1 ATE698 T1 AT E698T1
Authority
AT
Austria
Prior art keywords
alkyl
manufacture
pharmaceutical compositions
radical
acylaminot
Prior art date
Application number
AT79300756T
Other languages
English (en)
Inventor
Edward Douglas Brown
Original Assignee
Imperial Chemical Industries Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Plc filed Critical Imperial Chemical Industries Plc
Application granted granted Critical
Publication of ATE698T1 publication Critical patent/ATE698T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/46One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
AT79300756T 1978-05-26 1979-05-02 Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. ATE698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2293878 1978-05-26
EP79300756A EP0005911B1 (de) 1978-05-26 1979-05-02 Analgetische 6-Acylaminotetrahydro-1,3,5-Triazin-2,4-dion-Derivate, sie enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE698T1 true ATE698T1 (de) 1982-03-15

Family

ID=10187501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79300756T ATE698T1 (de) 1978-05-26 1979-05-02 Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (24)

Country Link
US (1) US4254122A (de)
EP (1) EP0005911B1 (de)
JP (1) JPS54154779A (de)
AT (1) ATE698T1 (de)
AU (1) AU529948B2 (de)
CA (1) CA1108138A (de)
CS (1) CS213377B2 (de)
DD (1) DD143906A5 (de)
DE (1) DE2962124D1 (de)
DK (1) DK213179A (de)
ES (1) ES480932A1 (de)
FI (1) FI66180C (de)
GR (1) GR68185B (de)
HU (1) HU180252B (de)
IE (1) IE49170B1 (de)
IL (1) IL57324A (de)
MW (1) MW1379A1 (de)
NO (1) NO791722L (de)
NZ (1) NZ190402A (de)
PH (1) PH14793A (de)
PT (1) PT69650A (de)
ZA (1) ZA792247B (de)
ZM (1) ZM4579A1 (de)
ZW (1) ZW9179A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
AU7080298A (en) * 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Triazine derivatives, their production and agrochemical composition
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
EP1494715A1 (de) * 2002-04-17 2005-01-12 Medical Research Council Fp rezeptor-antagonisten oder pgf2 alpha-antagonisten zur behandlung von menorrhagia
US20080152640A1 (en) * 2003-07-29 2008-06-26 Peter Prehm Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer
US7199156B2 (en) * 2003-10-10 2007-04-03 Milos Chvapil Composition and method to treat solid tumors
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
MX2008014828A (es) * 2006-05-22 2009-02-06 Combinatorx Inc Metodos y composiciones para el tratamiento de enfermedades o condiciones asociadas con niveles incrementados de proteina c-reactiva, interleucina-6 o interferon-gamma.
WO2009038708A1 (en) * 2007-09-19 2009-03-26 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
WO2009078998A1 (en) * 2007-12-17 2009-06-25 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
JP5692747B2 (ja) * 2009-02-13 2015-04-01 塩野義製薬株式会社 新規トリアジン誘導体およびそれを含有する医薬組成物
CN103153968B (zh) 2010-08-10 2016-02-03 盐野义制药株式会社 三唑衍生物及含有其的具有镇痛作用的药物组合物
EP2604260B1 (de) 2010-08-10 2017-05-10 Shionogi&Co., Ltd. Neue heterozyklische derivate und pharmazeutische zusammensetzung damit
US9550763B2 (en) 2012-02-09 2017-01-24 Shionogi & Co., Ltd. Heterocyclic ring and carbocyclic derivative
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
US20240076274A1 (en) * 2021-01-26 2024-03-07 Council Of Scientific And Industrial Research Triazine-based self-assembling system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983116A (en) * 1973-04-05 1976-09-28 E. I. Du Pont De Nemours And Company Herbicidal triazines
GB1464248A (en) 1973-11-01 1977-02-09 Ici Ltd Substituted triazinediones their preparation and use as herbicides
GB1543037A (en) * 1975-02-05 1979-03-28 Ici Ltd Selective herbicidal triazine-diones
US4082536A (en) * 1973-11-01 1978-04-04 Imperial Chemical Industries Limited Heterocyclic compounds and their use as pesticides
US4035365A (en) * 1973-11-01 1977-07-12 Imperial Chemical Industries Limited Triazinediones
GB1504304A (en) * 1974-02-15 1978-03-15 Ici Ltd Process of combating fungal and bacterial infections of plants with triazine dione derivatives
GB1599518A (en) * 1977-02-21 1981-10-07 Ici Ltd 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
GR68185B (de) 1981-11-09
ZW9179A1 (en) 1981-01-21
CS213377B2 (en) 1982-04-09
ZA792247B (en) 1980-05-28
JPS54154779A (en) 1979-12-06
DE2962124D1 (en) 1982-03-25
NZ190402A (en) 1982-05-31
FI66180C (fi) 1984-09-10
DD143906A5 (de) 1980-09-17
HU180252B (en) 1983-02-28
ES480932A1 (es) 1980-02-01
ZM4579A1 (en) 1981-05-21
AU529948B2 (en) 1983-06-30
IE49170B1 (en) 1985-08-21
FI791670A (fi) 1979-11-27
PT69650A (en) 1979-06-01
DK213179A (da) 1979-11-27
IE790889L (en) 1979-11-26
EP0005911B1 (de) 1982-02-17
AU4694979A (en) 1979-11-29
PH14793A (en) 1981-12-09
CA1108138A (en) 1981-09-01
IL57324A (en) 1983-10-31
EP0005911A1 (de) 1979-12-12
NO791722L (no) 1979-11-27
IL57324A0 (en) 1979-09-30
FI66180B (fi) 1984-05-31
MW1379A1 (en) 1981-04-08
US4254122A (en) 1981-03-03

Similar Documents

Publication Publication Date Title
ATE698T1 (de) Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
AU560179B2 (en) Hypoglycemic thiazolidinedione derivatives
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DK162519C (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne
DE68917023T2 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
DK491489D0 (da) Imidazolinderivater samt fremgangsmaade til fremstilling deraf
NO171915C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azabicyklo(4.2.0)okt-2-en-derivater
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES8403318A1 (es) Procedimiento de preparacion de nuevos derivados de la benzodioxina y de sus sales de adicion acida.
AU557494B2 (en) 2-substituted-5-arylimidazoles
SE8107524L (sv) Heterocykliska foreningar
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
DK22983A (da) Fremgangsmaade til fremstilling af penicillinderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee